# Genicular and Anterior Femoral Cutaneous Nerve Blocks for Total Knee Arthroplasty

> **NCT05980546** · PHASE4 · COMPLETED · sponsor: **Hospital for Special Surgery, New York** · enrollment: 244 (actual)

## Conditions studied

- Total Knee Replacement
- Genicular Nerve Block
- Opioid Use

## Interventions

- **DRUG:** Bupivacaine Injection
- **DRUG:** Dexamethasone injection
- **DRUG:** Fentanyl
- **DRUG:** Mepivacaine

## Key facts

- **NCT ID:** NCT05980546
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-07
- **Primary completion:** 2025-09-05
- **Final completion:** 2025-09-11
- **Target enrollment:** 244 (ACTUAL)
- **Last updated:** 2025-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05980546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05980546, "Genicular and Anterior Femoral Cutaneous Nerve Blocks for Total Knee Arthroplasty". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05980546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
